Axsome Therapeutics (AXSM) Return on Invested Capital (2024 - 2025)
Historic Return on Invested Capital for Axsome Therapeutics (AXSM) over the last 3 years, with Q3 2025 value amounting to 1.09%.
- Axsome Therapeutics' Return on Invested Capital rose 100.0% to 1.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.09%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.92% for FY2024, which is 1100.0% down from last year.
- Latest data reveals that Axsome Therapeutics reported Return on Invested Capital of 1.09% as of Q3 2025, which was up 100.0% from 1.07% recorded in Q2 2025.
- Over the past 5 years, Axsome Therapeutics' Return on Invested Capital peaked at 0.57% during Q4 2023, and registered a low of 1.15% during Q1 2025.
- In the last 3 years, Axsome Therapeutics' Return on Invested Capital had a median value of 1.08% in 2025 and averaged 0.99%.
- Its Return on Invested Capital has fluctuated over the past 5 years, first crashed by -5300bps in 2024, then surged by 100bps in 2025.
- Over the past 3 years, Axsome Therapeutics' Return on Invested Capital (Quarter) stood at 0.57% in 2023, then crashed by -94bps to 1.1% in 2024, then rose by 1bps to 1.09% in 2025.
- Its last three reported values are 1.09% in Q3 2025, 1.07% for Q2 2025, and 1.15% during Q1 2025.